Skip to main content
Fig. 2 | Cell Communication and Signaling

Fig. 2

From: The impact of erythroblast enucleation efficiency on the severity of anemia in patients with myelodysplastic syndrome

Fig. 2

The enucleation efficiency of erythroblasts and the expression levels of pERK and pAKT were significantly different in MDS patients with different prognosis stratifications. A Quantitative analysis statistics of erythroblast enucleation in the normal group, low-middle risk MDS group and high risk MDS group. The expression levels of pERK and pAKT in erythroblasts in the high risk MDS group were higher than those in the normal and low-middle risk MDS groups, and the expression levels of pERK and pAKT in the low-middle risk MDS group were lower than those in the normal and high risk MDS groups. B Western blotting was used to detect the expression levels of pERK and pAKT in day17 erythroblasts from MDS patients and the normal group. GAPDH served as the loading control. C Quantitative analysis of pERK protein expression statistics. D Quantitative analysis of pAKT protein expression statistics. The results are expressed as the mean ± SD and * represents p < 0.05, ** represents p < 0.01, and *** represents p < 0.001

Back to article page